Alpha Tau Appoints Industry Veteran Peter Melnyk as Chief Commercial Officer
01 sept. 2022 16h15 HE
|
Alpha Tau Medical Ltd.
JERUSALEM, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that...
Alpha Tau Medical to Participate in Upcoming September Investor Conferences
30 août 2022 16h05 HE
|
Alpha Tau Medical Ltd.
JERUSALEM, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced the...
Alpha Tau Medical Announces Second Quarter 2022 Financial Results and Provides Corporate Update
25 août 2022 16h05 HE
|
Alpha Tau Medical Ltd.
-Received FDA Conditional Investigational Device Exemption (IDE), whose conditions have since been satisfied, to initiate a pivotal trial of Alpha DaRT™ in recurrent cutaneous squamous cell carcinoma....
Alpha Tau and MIM Software Announce Collaboration for Alpha DaRT Treatment Planning
22 août 2022 09h00 HE
|
Alpha Tau Medical Ltd.
JERUSALEM and CLEVELAND, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Today, Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, and...
Alpha Tau Hosting Key Opinion Leader Meeting on Alpha DaRT Clinical Trials
05 juil. 2022 16h01 HE
|
Alpha Tau Medical Ltd.
JERUSALEM, July 05, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau" or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™,...
Alpha Tau Medical Initiates First Clinical Trial in Italy to Treat Cancer with Alpha Radiation
30 oct. 2017 07h30 HE
|
Alpha Tau Medical LTD.
TEL AVIV, Israel, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Alpha Tau Medical is happy to announce its first clinical trial in Italy. The study at IRST, Meldola, will evaluate the feasibility, safety and...
Alpha Tau Medical avvia la prima sperimentazione clinica in Italia per la cura del tumore con le radiazioni alfa
30 oct. 2017 04h40 HE
|
Alpha Tau Medical LTD.
TEL AVIV, Israele, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Alpha Tau Medical è lieta di annunciare l’avvio della sua prima sperimentazione clinica in Italia. Lo studio che sarà condotto presso l’IRST, a...